Literature DB >> 31037599

Comparative Efficacy of Bariatric Surgery in the Treatment of Morbid Obesity and Diabetes Mellitus: a Systematic Review and Network Meta-Analysis.

Chan Hyuk Park1, Seung-Joo Nam2, Hyuk Soon Choi3, Kyoung Oh Kim4, Do Hoon Kim5, Jung-Wook Kim6, Won Sohn7, Jai Hoon Yoon8, Sung Hoon Jung9, Yil Sik Hyun10, Hang Lak Lee11.   

Abstract

INTRODUCTION: The comparative efficacy of various bariatric procedures has not been completely elucidated. We aimed to evaluate efficacy and safety of various bariatric procedures comprehensively.
METHODS: We searched for randomized controlled trials investigating the efficacy of bariatric surgery. Network meta-analyses were performed to determine the percentage of excess weight loss (%EWL) and remission of diabetes mellitus (DM).
RESULTS: Of 45 studies, 33 and 24 provided the data for %EWL and DM remission rates, respectively. Six months after surgery, biliopancreatic diversion with duodenal switch (BPD-DS), Roux-en-Y gastric bypass (RYGB), and sleeve gastrectomy (SG) showed superior efficacy for %EWL compared to the standard-of-care (mean difference [MD], [95% confidence interval [CI]]: BPD-DS, 38.2% [7.3%, 69.1%]; RYGB, 32.1% [3.1%, 61.1%]; SG, 32.5% [5.5%, 59.5%]). However, adjustable gastric banding was not superior to standard-of-care (MD [95% CI] = - 0.2% [- 19.6%, 19.2%]). At 1 year, all bariatric procedures were superior to standard-of-care. At 3 years, RYGB and SG showed superior efficacy when compared to standard-of-care (MD [95% CI]: RYGB, 45.0% [21.8%, 68.2%]; SG, 39.2% [15.2%, 63.3%]). With respect to DM remission 3-5 years after surgery, BPD-DS, RYGB, and SG were superior to standard-of-care. Hernias, obstruction/stricture, bleeding, and ulcers were less common in patients who underwent SG than in those who underwent RYGB.
CONCLUSIONS: RYGB and SG had excellent long-term outcomes for both the %EWL and DM remission rates. Additionally, SG had a relatively lower risk of adverse events than RYGB.

Entities:  

Keywords:  Bariatric surgery; Diabetes; Excessive weight loss; Metabolic surgery; Network meta-analysis

Mesh:

Year:  2019        PMID: 31037599     DOI: 10.1007/s11695-019-03831-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  56 in total

1.  Bariatric surgery versus conventional medical therapy for type 2 diabetes.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Laura Leccesi; Giuseppe Nanni; Alfons Pomp; Marco Castagneto; Giovanni Ghirlanda; Francesco Rubino
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

2.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

3.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Ali Aminian; Stacy A Brethauer; Sankar D Navaneethan; Rishi P Singh; Claire E Pothier; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

4.  Bariatric Surgery Worldwide 2013.

Authors:  L Angrisani; A Santonicola; P Iovino; G Formisano; H Buchwald; N Scopinaro
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

Review 5.  The evolution of metabolic/bariatric surgery.

Authors:  Henry Buchwald
Journal:  Obes Surg       Date:  2014-08       Impact factor: 4.129

6.  Is laparoscopic duodenojejunal bypass with sleeve an effective alternative to Roux en Y gastric bypass in morbidly obese patients: preliminary results of a randomized trial.

Authors:  P Praveen Raj; R Kumaravel; C Chandramaliteeswaran; S Rajpandian; C Palanivelu
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

Review 7.  Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.

Authors:  Henry Buchwald; Rhonda Estok; Kyle Fahrbach; Deirdre Banel; Michael D Jensen; Walter J Pories; John P Bantle; Isabella Sledge
Journal:  Am J Med       Date:  2009-03       Impact factor: 4.965

8.  Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity.

Authors:  T T Søvik; O Taha; E T Aasheim; M Engström; J Kristinsson; S Björkman; C F Schou; H Lönroth; T Mala; T Olbers
Journal:  Br J Surg       Date:  2010-02       Impact factor: 6.939

9.  Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014.

Authors:  L Angrisani; A Santonicola; P Iovino; A Vitiello; N Zundel; H Buchwald; N Scopinaro
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

10.  Effects of bariatric surgery on mortality in Swedish obese subjects.

Authors:  Lars Sjöström; Kristina Narbro; C David Sjöström; Kristjan Karason; Bo Larsson; Hans Wedel; Ted Lystig; Marianne Sullivan; Claude Bouchard; Björn Carlsson; Calle Bengtsson; Sven Dahlgren; Anders Gummesson; Peter Jacobson; Jan Karlsson; Anna-Karin Lindroos; Hans Lönroth; Ingmar Näslund; Torsten Olbers; Kaj Stenlöf; Jarl Torgerson; Göran Agren; Lena M S Carlsson
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

View more
  12 in total

1.  The Effect of Single-Anastomosis Sleeve Ileal (SASI) Bypass on Patients with Severe Obesity in Three Consecutive Years.

Authors:  Seyed Vahid Hosseini; Nader Moeinvaziri; Pourya Medhati; Safa Aldin Salem; Elnaz Hosseini; Cain C T Clark; Neda Haghighat
Journal:  World J Surg       Date:  2022-08-21       Impact factor: 3.282

2.  Effect of Obesity and Roux-En-Y Gastric Surgery on Omeprazole Pharmacokinetics.

Authors:  Antonio Portolés-Pérez; Ana Belén Rivas Paterna; Andrés Sánchez Pernaute; Antonio José Torres García; Carmen Moreno Lopera; Luis M Chicharro; Fernando Bandrés; Amanda López-Picado; Miguel A Rubio; Emilio Vargas Castrillón
Journal:  Obes Facts       Date:  2022-01-03       Impact factor: 4.807

Review 3.  Incremental Net Monetary Benefit of Bariatric Surgery: Systematic Review and Meta-Analysis of Cost-Effectiveness Evidences.

Authors:  Prapaporn Noparatayaporn; Montarat Thavorncharoensap; Usa Chaikledkaew; Bhavani Shankara Bagepally; Ammarin Thakkinstian
Journal:  Obes Surg       Date:  2021-04-24       Impact factor: 4.129

4.  Patient Access, Utilization, and Perceptions of Neighborhood and Built Environment Resources.

Authors:  Keeley J Pratt; Jamie Blalock; Lindsay Breslin; Haley Kiser; Andrew Hanks; Brian C Focht; Michael Outrich; Sabrena Noria; Bradley Needleman
Journal:  Obes Surg       Date:  2021-11-16       Impact factor: 3.479

5.  Bariatric surgery versus medical therapy in Korean obese patients: prospective multicenter nonrandomized controlled trial (KOBESS trial).

Authors:  Do Joong Park; Sena An; Young Suk Park; Joo-Ho Lee; Hyuk-Joon Lee; Tae Kyung Ha; Yong-Jin Kim; Seung-Wan Ryu; Sang-Moon Han; Moon-Won Yoo; Sungsoo Park; Sang-Uk Han; Jae-Heon Kang; Jin-Won Kwon; Yoonseok Heo
Journal:  Ann Surg Treat Res       Date:  2021-10-01       Impact factor: 1.859

6.  Network Meta-Analysis of Metabolic Surgery Procedures for the Treatment of Obesity and Diabetes.

Authors:  Andrew C Currie; Alan Askari; Ana Fangueiro; Kamal Mahawar
Journal:  Obes Surg       Date:  2021-08-07       Impact factor: 3.479

Review 7.  Comparative effectiveness of bariatric surgeries in patients with obesity and type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.

Authors:  Li Ding; Yuxin Fan; Hui Li; Yalan Zhang; Dongwang Qi; Shaofang Tang; Jingqiu Cui; Qing He; Chuanjun Zhuo; Ming Liu
Journal:  Obes Rev       Date:  2020-04-14       Impact factor: 9.213

8.  Temporal Effects of Sleeve Gastrectomy on Glucose-Insulin Homeostasis and Incretin Hormone Response at 1 and 6 Months.

Authors:  S L Prior; R Churm; T Min; G J Dunseath; J D Barry; J W Stephens
Journal:  Obes Surg       Date:  2020-06       Impact factor: 4.129

Review 9.  Drug Therapy in Obesity: A Review of Current and Emerging Treatments.

Authors:  David M Williams; Asif Nawaz; Marc Evans
Journal:  Diabetes Ther       Date:  2020-04-15       Impact factor: 2.945

Review 10.  The Effect of Metabolic Surgery on the Complications of Diabetes: What Are the Unanswered Questions?

Authors:  Karl J Neff; Carel W Le Roux
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-29       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.